Summary Pituitary tumours develop at a high frequency in p27-knockout mice and retinoblastoma gene-knockout mice, which suggests that cell cycle regulatory genes, such as cyclin-dependent kinase inhibitor genes, are involved in the tumorigenesis of pituitary adenoma. Analysis of p21 and p27 gene abnormalities in human pituitary adenoma was performed in 28 pituitary adenomas by polymerase chain reaction-single-strand conformational polymorphism. No point mutations were detected in these genes. As no abnormalities of the p21 and p27 genes were observed, and if these genes are indeed inactivated, it is likely to be via transcriptional or translational defects.
transcription polymerase chain reaction
Control of cell proliferation is managed by a series of checkpoints that regulate cell cycle progression. In recent years, molecular analysis has revealed various abnormalities in the regulatory genes (MacLachlan et al, 1995; Pines, 1995) . Retinoblastoma protein (pRb) is a critical target of these cell cycle regulatory genes to promote progression through the G, phase of the cell cycle.
Sequential activation of cyclin, cyclin-dependent kinase (CDK) complexes is thought to be responsible for orderly transitions through the cell cycle (MacLachlan et al, 1995; Pines, 1995) . The abnormal activation of CDK activity leads to underphosphorylation of pRb and may underlie the uncontrolled growth that characterizes neoplasms. The family of low-molecular-weight CDK inhibitors, which includes p15, p16, p2] and p27 gene products, is essential in arresting cell cycle progression (MacLachlan et al, 1995; Pines, 1995) .
The high incidence of spontaneous pituitary adenoma (almost 100%) that develops in heterozygous Rb-knockout mice (Jacks et al, 1992; Hu et al, 1994) implicates the Rb pathway in pituitary tumorigenesis, although mutation of the Rb gene itself is infrequent in human pituitary adenoma (Cryns et al, 1993; Ikeda et al, 1995) . Recently, the homozygous p27-knockout mouse was found to develop a high incidence of pituitary adenoma (Fero et al, 1996; Kiyokawa et al, 1996; Nakayama et al, 1996) . Both the Rb mutation and the p27-'-mice developed morphologically similar tumours originating in the pars intermedia of the pituitary gland. Therefore, the p27 and Rb functions are thought to be in the same regulatory pathway and are important in the tumorigenesis of pituitary adenoma in mice.
The present study investigated genetic changes in p21 and p27 in human pituitary adenomas using polymerase chain reaction (PCR)-single-strand conformational polymorphism (SSCP) analysis and direct sequencing. RNA isolation mRNA was isolated from tissues using the QuickPrepR Micro mRNA purification kit, which combines the disruptive and protective properties of guanidinium thiocyanate with the speed and selectivity of oligo(dT)-cellulose chromatography in a spuncolumn format (Pharmacia Biotech, Tokyo, Japan).
MATERIALS AND METHODS

Human tissue samples
Reverse transcription (RT)-PCR analysis of p21
Full-length first-strand cDNA was obtained by mixing mRNA template (33 Iil) and First-Strand Reaction Mix (T-primed firststrand kit; Pharmacia Biotech). The first-strand cDNA was amplified in a 100 gl mixture containing 6 jul of the first-strand reaction, 
PCR-SSCP analysis PCR primer pairs for the amplification of the cDNA of p2] and genomic DNA of p27 were synthesized by Japan Genetic Research (Sendai, Japan) ( Figure 1 and Table 2 ). PCR fragments were generated from 3 to 6,l of the amplified cDNA solution in The magnesium chloride concentration and pH of the amplification reaction mixture were optimized for each primer pair. The samples were denatured at 94°C for 5 min. PCR amplification (35-45 cycles) was then carried out using cycles of 1 min 15 s at 94°C (denaturation), 1 min 30 s at 50-55°C (annealing) and 2 min at 71PC (polymerization) using a programmable thermal cycler (PC-800; ASTEC, Fukuoka, Japan). The final polymerization step was performed for 5 min at 71°C. The annealing temperature was optimized for each set of primers. PCR-amplified product solution (5 pl) was then mixed with 5 p1 of loading solution (95% formamide, 20 mm EDTA, 0.05% xylene cyanol). Diluted samples were denatured at 95°C for 5 min, then loaded on 6% nondenaturing polyacrylamide gels (firstly on a gel containing 10% glycerol and secondly on a gel without glycerol). Electrophoresis (1997) 76(9), [1119] [1120] [1121] [1122] [1123] . was performed both at room temperature and 4°C (cold room) at a constant power of 2-13 W for 6-16 h. Autoradiography was carried out for 5-48 h without an intensifying screen.
DNA sequencing analysis
The amplified genomic DNA or cDNA fragments used for direct sequencing were purified using Microspin Columns (Pharmacia Biotech). Genomic DNA or cDNA fragments were sequenced in both sense and antisense directions using an ALFred DNA Sequencer (Pharmacia Biotech).
RESULTS
SSCP of the p21 gene
The cDNA of the p2] gene was divided into segments 1, 2 and 3.
No shifted bands were detected in segment 1, 2 or 3 (Figure 2 ), suggesting that neither point mutations nor polymorphisms were present.
SSCP of the p27 gene
The coding region of the p27 gene consists of two exons (1 and 2). Exon 1 was divided into three segments (1-A, 1-B and 1-C) for detection of mutations by PCR-SSCP. No band shifts were detected in segments exon 1-A, exon 1-C or in exon 2 ( Figure 3A , C and D). However, three specimens (case 2, 24 and 26) showed band shifting in exon 1-B and exon 1-[B+C] ( Figure 3B ). Sequence analysis of these three specimens showed no mutation or polymorphism.
DISCUSSION
Analysis of 28 specimens of human pituitary tumour found no mutations in the coding region of the p27 gene. We also found no mutation of the coding region of p21. Although p27 protein has homology to the p21 protein and is thought to belong to the products of the same gene family Toyoshima and Hunter, 1994) ; mice lacking p21 do not develop pituitary tumours (Deng et al, 1995 ). An inverse relationship between p16 and pRb inactivation has been found in tumours such as lung cancer and malignant glioma (Hu et al, 1994; Ueki et al, 1996) , which suggests a common regulatory mechanism for pl6 and Rb functions. Recent p16 gene analysis found no abnormality in 25 specimens of human pituitary adenoma (Woloschak et al, 1996) . Therefore, no abnormalities in the p16, p21 or p27 genes, which regulate cell proliferation by suppressing hyperphosphorylation and functional inactivation of pRb, are present in human pituitary adenomas.
The embryological morphogenesis of the intermediate lobe of the pituitary gland is unique for each species, but that of the mouse is very similar to that of humans [Ikeda et al, 1988; Ikeda and Yoshimoto, 1991] . Pituitary tumours arising from the intermediate lobe are frequently observed in mice with germline mutation of the p27 gene. Therefore, a similar gene abnormality may occur in human pituitary tumours. Reduced levels of p16 protein and mRNA have been detected in human pituitary tumours, although no p16 gene mutation or gene loss was found. This altered expression of the p16 gene products occurs at a high frequency in human pituitary adenoma (Woloschak et al, 1996) and is due to gene methylation, which interferes with transcription of the gene.
No somatic mutations of the p21 gene were found in 158 patients with brain tumour (Koopman et al, 1995) , and no mutation of this gene was found in 351 DNA specimens from various kinds of malignancies (Shirohara, 1994) . Thus, we can speculate that p2] gene mutations are not involved in the formation of human tumours (Koopman et al, 1995) . No mutations of the p27 gene were found in seven patients with leukaemias (Pietenpol et al, 1995) , in more than 20 patients with chronic lymphocytic leukaemia (Bullrich et al, 1995) and in 147 patients with various kinds of malignant solid tumours [Ponce-Castaneda et al, 1995] .
However, p27 acts as a stoichiomeric inhibitor of G, cyclin-CDKs and even modest changes in the relative levels of p27 can have a major effect on G1 progression (Kato et al, 1994) . According to Hengst and Reed (1996) , as variation in the amount of p27 protein occurred, the cell cycle function of p27 was regulated at the level of protein accumulation by post-transcriptional mechanisms, whereas the abundance of the p27 messenger RNA remained unchanged. These findings suggest that further work is required to clarify other mechanisms, such as transcriptional or translational defects, that inactivate the p27 gene and other genes that cause underphosphorylation of pRb.
